A Study to Assess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia With 17p Deletion
Clinical trial NCT03190330 · COMPLETED
Trial details
- NCT number
- NCT03190330
- Sponsor
- Johnson & Johnson Private Limited
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-26
- Primary completion
- 2023-05-03
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.